Insilico Medicine, an AI-driven drug discovery company, raised $110 million in Series E funding to propel its AI platform Pharma.AI, advance its drug pipeline, and bolster biopharmaceutical R&D, harnessing biology, clinical data, and generative chemistry for innovative drug development.
Academics from Chicago universities protested planned cuts to federal research grants, while a judge temporarily blocked the NIH from implementing the controversial cuts ordered by the Trump administration, which critics argue would hamper vital medical research and public health initiatives nationwide.
Rare diseases affect millions but face an uphill battle for diagnosis, treatment, and research due to their rarity, despite efforts like federal incentives and patient advocacy, underscoring the need for increased focus to unlock medical insights and cures.
ReviveMed unveiled an AI-powered metabolomics platform with mzLearn algorithm for automated metabolite detection, enabling pre-trained generative AI models that outperformed clinical risk scores in predicting renal cell carcinoma outcomes, paving the way for precision medicine breakthroughs.
Google unveiled an experimental AI 'co-scientist' system that synthesizes research, generates hypotheses, and suggests plans, leveraging large language models and techniques like literature search, with early users enthusiastic but uncertainty around true novelty.
In a groundbreaking AI breakthrough, FragFold, an innovative system leveraging AlphaFold's machine learning capabilities, accurately predicts protein fragments that can inhibit target proteins, experimentally confirming over 50% of its predictions and unlocking new frontiers in drug discovery by enabling deeper insights into protein interactions.
Evo 2, a groundbreaking AI tool, unlocks the secrets of nature's genetic code, enabling rapid protein discovery by virtually predicting the form and function of proteins encoded in the DNA of all living and extinct species, potentially revolutionizing biological research and accelerating scientific breakthroughs.
Alarming mass terminations of federal scientists responsible for public health, safety, and environmental protection have sparked widespread concerns over potential risks to air travel, medical device safety, wildlife habitats, and national parks.